There are 594 resources available
367P - Clinical characteristics and ctDNA as prognostic tools in KRAS-mutated NSCLC during first line treatment (1L)
Presenter: PAULA ESPINOSA OLARTE
Session: Poster Display session
368P - Molecular diagnosis of lung cancer via ctDNA and ctRNA detection on bronchoscopic fluid: A bicenter prospective study (BiLiBro)
Presenter: Gabrielle Danino
Session: Poster Display session
369P - Biological correlates of cell free DNA (cfDNA) tumor fraction (TF) in advanced NSCLC
Presenter: Filippo Dall'Olio
Session: Poster Display session
370P - Transcriptome data-based prognosis prediction model for lung adenocarcinoma using an image deep learning approach
Presenter: hsuanyu chen
Session: Poster Display session
371P - Lung.cregmap: A web application to explore lung cancer heterogeneity through its coregulation network
Presenter: Geoffrey Pawlak
Session: Poster Display session
372P - Sympathetic signals promote immunosuppressive neutrophils for tumor progression in the lung
Presenter: Ruoyi Jin
Session: Poster Display session
Resources:
Abstract
373P - Dissecting the impact of controlling nutritional status (CONUT) score on survival outcomes and immune-inflammatory profiles in patients with advanced NSCLC undergoing chemo-immunotherapy
Presenter: Giulia Mazzaschi
Session: Poster Display session
374P - Prognostic relevance of post-cycle 1 pembrolizumab levels in real-world NSCLC patients receiving first line IO or ChIO
Presenter: Cristina Martinez
Session: Poster Display session
375P - Multi-omics revealed unique metabolic resistance mechanisms to third-generation EGFR-TKI in EGFR-mutant non-small cell lung cancer
Presenter: Ruyun Gao
Session: Poster Display session
376P - Crosstalk Between CAFs and Cancer Cells is mediated by hMENA-regulated secretory autophagy and affects immunotherapy response in NSCLC
Presenter: Annalisa Tocci
Session: Poster Display session